Scientific Opinion on the substantiation of health claims related to
Fagopyrum esculentum Moench. and function of the upper respiratory
tract (ID 2442) pursuant to Article 13(1) of Regulation (EC) No 1924/2006[sup]1[/sup]
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2
European Food Safety Authority (EFSA), Parma, Italy
Słowa kluczowe:
Fagopyrum esculentum Moench
1. Charakterystyka żywności / składnika
-
Prawidłowe funkcjonowanie górnych dróg oddechowych
The food constituent that is the subject of the claim is Fagopyrum esculentum Moench.. The characterisation of Fagopyrum esculentum Moench. is performed by comparing data provided as conditions of use to information extracted from standard reference textbooks (see Table 2 and Appendix C for list of standard reference textbooks used for the characterisation).
Table 2. Information on Fagopyrum esculentum Moench. from standard reference textbooks and the information provided as conditions of use.
ID Scientific name Part used
Nature of the
preparation Conditions of use
Text-
book
Fagopyrum
esculentum Moench.
= F. sagittatum Gilib.
= F. tataricum (L.)
Gaertn. = F. vulgare
Hill.
Polygonaceae
Flower
; fruit;
leaf
Powder;
infusion
Fruit:
Powder: amount not specified.
Leaf:
Infusion: 2 g/150 mL. Exempt of
fagopyrine.
Note for fagopyrine: risk of
photosensitisation (leaf: up to 0.05%,
flower up to 0.08%).
2442 Fagopyrum
esculentum Moench.
(Buckwheat)
Flower Not specified
Note: it is
assumed to be
the dried form
Flower: 900 mg / Used as part of a
multibotanical combination.
Notes: the daily amount is not specified.
The nature of the preparation is not specified, but it is assumed to be the dried form. The daily amount is not specified. The Panel notes that the consolidated list contains insufficient information to allow a characterisation of Fagopyrum esculentum Moench..
The Panel notes that there is no information on the other components of the multibotanical combination.
The Panel considers that the food constituent, Fagopyrum esculentum Moench., which is the subject of the health claim, has not been sufficiently characterised.
2. Znaczenie oświadczenia dla zdrowia człowieka
-
Prawidłowe funkcjonowanie górnych dróg oddechowych
The claimed effect is “respiratory health”. The Panel assumes that the target population is the general population.
The claimed effect “respiratory health” is not sufficiently defined. In the context of the proposed wording, the Panel assumes that the claim refers to the normal function of the upper respiratory tract.
The Panel considers that normal function of the upper respiratory tract is beneficial to human health.
3. Naukowe uzasadnienia wpływu na zdrowie człowieka - Prawidłowe funkcjonowanie górnych dróg oddechowych
-
Prawidłowe funkcjonowanie górnych dróg oddechowych
One reference was cited to substantiate the claimed effect. This reference was not accessible to the Panel, even after every reasonable effort was made to retrieve it.
The Panel concludes that a cause and effect relationship has not been established between the consumption of Fagopyrum esculentum Moench. and normal function of the upper respiratory tract.
Wnioski
On the basis of the data presented, the Panel concludes that:
The food constituent, Fagopyrum esculentum Moench., which is the subject of the health claim, has not been sufficiently characterised.
The claimed effect is “respiratory health”. The target population is assumed to be the general population. Normal function of the upper respiratory tract is beneficial to human health.
A cause and effect relationship has not been established between the consumption of Fagopyrum esculentum Moench. and normal function of the upper respiratory tract.
